Filing Flows

Filing Flows › 8-K events › Accendra Health

Accendra Health: notice of delisting or failure to meet a listing standard

Form 8-K filed Oct 30, 2026 · items 3.01, 7.01

Delisting noticesAccendra Health Receives Continued Listing Standard Notice from NYSE Regarding Market Capitalization and Stockholders’ Equity;

What the filing says

On October 27, 2026, Accendra Health, Inc. (the “Company”) received notice (the “Notice”) from the New York Stock Exchange (the “NYSE”) that it was not in compliance with the continued listing standard set forth in Section 802.01B of the NYSE’s Listed Company Manual (“Section 802.01B”) that the Company have an average

Read the filing on SEC EDGAR →

What usually followsAcross 492 8-Ks reporting Item 3.01 (delisting notice or listing-rule failure) in our universe, the stock's median move the next session was 0.0% (typical size ±2.1%, up 46% of the time); over the following 21 sessions, −0.2%. Every item ranked →

What this kind of filing means

Item 3.01 — Notice of delisting or failure to meet a listing standard. A delisting notice starts a compliance window; companies often answer with a reverse split, a plan, or a move to another market.

Accendra Health at a glance

Latest quarterQ3 2026
Revenue$601.8M
Revenue Y/Y-14%
Operating margin0.2%
IndustryWholesale-Medical, Dental & Hospital Equipment & Supplies

Accendra Health, Q3 2026: revenue $602M (-14% year over year), operating margin 0.2%. The chart follows the revenue to costs, profit and cash.

Accendra Health: every quarter, Q/Q and Y/Y, holders and guidance →

Accendra Health’s other material 8-Ks

Other recent delisting notices

Read automatically from SEC EDGAR (13F, Form 4, Form 144, Schedule 13D/G, 8-K, XBRL), House and Senate disclosures, FINRA and exchange data; errors are possible. Not investment advice.